Byron Capital Markets

Byron Capital Markets

November 02, 2011 09:46 ET

Byron Capital Markets Initiates Research Coverage on the Healthcare and Biotechnology Sectors

TORONTO, ONTARIO--(Marketwire - Nov. 2, 2011) - Byron Capital Markets Ltd. is pleased to announce that Byron's Doug Loe (B.Sc., M.Sc., Ph.D., MBA), Research Analyst (Global Healthcare and Biotechnology), has launched investment research coverage on the healthcare and biotechnology sectors with the distribution of a research report compilation dated November 2, 2011.

In 2005 and 2010, Doug was recognized by StarMine/National Post as one of Canada's top healthcare analysts. The StarMine Analyst Awards and StarMine Broker Rankings recognize a country's top individual analysts and sell-side firms based on the objective measurement of their estimate accuracy and recommendation performance. In 2005, Doug was ranked #1 in the "Top Stock Pickers" category for the Healthcare sector and in 2010 he was ranked #3 in that category.

With the launch of investment research coverage concerning this perpetually important industry for the future, Byron will be servicing issuer clients in the healthcare and biotechnology fields, as well as related fields such as life sciences, medical technology and pharmaceuticals. Byron will also be providing advice and services to investors concerning investment opportunities and strategies related to these fields.

Mr. Loe's initiation report provides in-depth coverage on 22 companies, all of which are listed on the Toronto Stock Exchange or TSX Venture Exchange. This breadth of coverage launches Byron into the leadership position of independent investment dealers in Canada in terms of the number of healthcare and biotechnology issuers under coverage.

These efforts in healthcare and biotechnology exemplify Byron's continuing commitment to investment research and, in particular, Byron's ongoing efforts towards "Financing and Advising the Intellectual Revolution".

About Byron Capital Markets Ltd.:

Byron Capital Markets Ltd. is an innovative, intellectually-driven and independent investment dealer focused on providing an unparalleled level of service to institutional investors and to corporate clients throughout the lifecycle of their businesses. More information about Byron is available at

Contact Information